Evaluation of Arrhythmia Risk in Children with Type 1 Diabetes Mellitus
PDF

Original Article

Evaluation of Arrhythmia Risk in Children with Type 1 Diabetes Mellitus

J Clin Res Pediatr Endocrinol 2025;17(2):146-152 DOI: 10.4274/jcrpe.galenos.2024.2024-7-28
, , , , ,
PDF
Permissions

Abstract

Objective

Children with type 1 diabetes mellitus (T1DM) are susceptible to cardiac arrhythmias and even sudden cardiac death. The aim of this study was to explore the risk of arrhythmia among children with T1DM by assessing electrocardiographic (ECG) parameters.

Methods

Children diagnosed with T1DM, aged 10-18 years, and healthy children matched for age and gender were included. The ECG ventricular depolarization-repolarization parameters of both groups and the correlation of these parameters with length of time since diagnosis of T1DM, markers of metabolic control, and the presence of additional complications were evaluated.

Results

There were 165 children with type 1 diabetes and 154 controls in the groups, which were similar in for age, gender, weight, height, and body mass index. The median length of time since diagnosis of diabetes was 5 years. QT (maximum), QTc (minimum and maximum), QT and QTc dispersion, Tp-e (minimum and maximum), Tp-e dispersion, and Tp-e/QTc-maximum values were significantly higher in the diabetic group compared with controls, although QTc intervals were within normal ranges. No significant correlation was observed between ECG findings and length of time since diagnosis of T1DM, HbA1c levels, or complications.

Conclusion

As children with T1DM are at high risk of impaired ventricular depolarization and repolarization, they should undergo cardiac assessment and regular annual ECG monitoring.

Keywords: Children, diabetes, dispersion, arrhythmia, sudden death

Read the full text

5 sections · 1 figure · 3 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC; International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group; Magliano DJ, Maniam J, Orchard TJ, Rai P, Ogle GD. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10:741-760. Epub 2022 Sep 13.

2

Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, Aschner P, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):7-19.

3

Lynge TH, Svane J, Pedersen-Bjergaard U, Gislason G, Torp-Pedersen C, Banner J, Risgaard B, Winkel BG, Tfelt-Hansen J. Sudden cardiac death among persons with diabetes aged 1-49 years: a 10-year nationwide study of 14 294 deaths in Denmark. Eur Heart J. 2020;41:2699-2706.

4

Gregory JW, Cameron FJ, Joshi K, Eiswirth M, Garrett C, Garvey K, Agarwal S, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: diabetes in adolescence. Pediatr Diabetes. 2022;23:857-871.

5

Agashe S, Petak S. Cardiac autonomic neuropathy in diabetes mellitus. Methodist Debakey Cardiovasc J. 2018;14:251-256.

6

Donaghue KC, Marcovecchio ML, Wadwa RP, Chew EY, Wong TY, Calliari LE, Zabeen B, Salem MA, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2018;19 Suppl 27: 262-274.

7

Chalakova T, Yotov Y, Tzotchev K, Galcheva S, Balev B, Bocheva Y, Usheva N, Iotova V. Type 1 diabetes mellitus - risk factor for cardiovascular disease morbidity and mortality. Curr Diabetes Rev. 2021;17:37-54.

8

Balgobin S, Basak S, Teoh CW, Noone D. Hypertension in diabetes. Pediatr Nephrol. 2024;39:1739-1758. Epub 2023 Oct 13.

9

Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical Practice Guideline for screening and management of high blood pressure in children and adolescents. 2017;140:e20171904. Epub 2017 Aug 21.

10

Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan NA, Kuyper LM, Lamarre-Cliche M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Sivapalan P, Townsend RR, Tran K, Trudeau L, Tsuyuki RT, Vallée M, Woo V, Bell AD, Daskalopoulou SS. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36:596-624.

11

Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wühl E, Zanchetti A. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887-1920.

12

Vurallı D, Jalilova L, Alikaşifoğlu A, Özön ZA, Gönç EN, Kandemir N. Cardiovascular risk factors in adolescents with type 1 diabetes: prevalence and gender differences. J Clin Res Pediatr Endocrinol. 2024;16:11-20. Epub 2023 Aug 10.

13

Craig ME, Codner E, Mahmud FH, Marcovecchio ML, DiMeglio LA, Priyambada L, Wolfsdorf JI. ISPAD Clinical Practice Consensus Guidelines 2022: Editorial. Pediatr Diabetes. 2022;23:1157-1159.

14

Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567-574. Epub 2008 Sep 14.

15

Bezen D, Türkmenoğlu Y, İrdem A. Ventricular depolarization and repolarization variability in children with type 1 diabetes mellitus. Pediatr Int. 2022;64:e15290.

16

Svane J, Pedersen-Bjergaard U, Tfelt-Hansen J. Diabetes and the risk of sudden cardiac death. Curr Cardiol Rep. 2020;22:112.

17

Welten SJGC, Elders PJM, Remmelzwaal S, Doekhie R, Kee KW, Nijpels G, van der Heijden AA; ESCAPE-NET investigators. Prolongation of the heart rate-corrected QT interval is associated with cardiovascular diseases: systematic review and meta-analysis. Arch Cardiovasc Dis. 2023;116:69-78. Epub 2023 Jan 7.

18

Zhang Y, Post WS, Blasco-Colmenares E, Dalal D, Tomaselli GF, Guallar E. Electrocardiographic QT interval and mortality: a meta-analysis. Epidemiology. 2011;22:660-670.

19

Galli-Tsinopoulou A, Chatzidimitriou A, Kyrgios I, Rousso I, Varlamis G, Karavanaki K. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval. J Pediatr Endocrinol Metab. 2014;27:237-243.

20

Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care. 2000;23:1381-1383.

21

Isaksen JL, Graff C, Ellervik C, Jensen JS, Rossing P, Kanters JK, Jensen MT. Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control study. Diabet Med. 2018;35:1337-1344. Epub 2018 Jun 2.

22

Bazoukis G, Yeung C, Wui Hang Ho R, Varrias D, Papadatos S, Lee S, Ho Christien Li K, Sakellaropoulou A, Saplaouras A, Kitsoulis P, Vlachos K, Lampropoulos K, Thomopoulos C, Letsas KP, Liu T, Tse G. Association of QT dispersion with mortality and arrhythmic events-A meta-analysis of observational studies. J Arrhythm. 2019;36:105-115.

23

Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36:1749-1766.

24

Uysal F, Ozboyaci E, Bostan O, Saglam H, Semizel E, Cil E. Evaluation of electrocardiographic parameters for early diagnosis of autonomic dysfunction in children and adolescents with type-1 diabetes mellitus. Pediatr Int. 2014;56:675-680. Epub 2014 Sep 17.

25

Giunti S, Gruden G, Fornengo P, Barutta F, Amione C, Ghezzo G, Cavallo-Perin P, Bruno G. Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study. Diabetes Care. 2012;35:581-583. Epub 2012 Feb 1.

26

Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, Christ ER, Teuscher A, Diem P. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia. 2007;50:186-194. Epub 2006 Nov 10.

27

Türe M, Akın A, Unal E, Kan A, Savaş S. Electrocardiographic data of children with type 1 diabetes mellitus. Cardiol Young. 2022;32:106-110. Epub 2021 Nov 2.

28

Demirol M, Karadeniz C, Ozdemir R, Çoban Ş, Katipoğlu N, Yozgat Y, Meşe T, Unal N. Prolonged Tp-e interval and Tp-e/QT ratio in children with mitral valve prolapse. Pediatr Cardiol. 2016;37:1169-1174. Epub 2016 Jun 1.

29

Mandala S, Di TC. ECG parameters for malignant ventricular arrhythmias: a comprehensive review. J Med Biol Eng. 2017;37:441-453.

30

Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, Gunson K, Jui J, Chugh SS. Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol. 2011;4:441-447. Epub 2011 May 18.

31

Eğil O, Şap F, Selver Eklioğlu B, Oflaz MB, Atabek ME, Baysal T. First evaluation of P dispersion and Tp-e parameters in electrocardiograms of children with diabetic ketoacidosis. J Clin Res Pediatr Endocrinol. 2022;14:37-45. Epub 2021 Aug 18.

32

Inanır M, Gunes Y, Sincer I, Erdal E. Evaluation of electrocardiographic ventricular depolarization and repolarization variables in type 1 diabetes mellitus. Arq Bras Cardiol. 2020;114:275-280.

33

de Bock M, Codner E, Craig ME, Huynh T, Maahs DM, Mahmud FH, Marcovecchio L, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23:1270-1276.